292 related articles for article (PubMed ID: 17532533)
1. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.
Fitzgerald MF; Fox JC
Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
Fitzgerald MF; Fox JC
Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
[TBL] [Abstract][Full Text] [Related]
3. The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
Fox JC; Fitzgerald MF
Curr Opin Pharmacol; 2009 Jun; 9(3):231-42. PubMed ID: 19356979
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
Donnelly LE; Barnes PJ
Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
[TBL] [Abstract][Full Text] [Related]
5. Perspectives for cytokine antagonist therapy in COPD.
de Boer WI
Drug Discov Today; 2005 Jan; 10(2):93-106. PubMed ID: 15718158
[TBL] [Abstract][Full Text] [Related]
6. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
7. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
Beeh KM; Beier J
Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
[TBL] [Abstract][Full Text] [Related]
8. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD.
Morjaria JB; Malerba M; Polosa R
Drug Discov Today; 2010 May; 15(9-10):396-405. PubMed ID: 20223295
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment.
Mroz RM; Holownia A; Chyczewska E; Braszko JJ
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631
[TBL] [Abstract][Full Text] [Related]
10. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
Séguin RM; Ferrari N
Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
[TBL] [Abstract][Full Text] [Related]
11. New treatments for chronic obstructive pulmonary disease.
Barnes PJ
Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577
[TBL] [Abstract][Full Text] [Related]
12. COPD: is there light at the end of the tunnel?
Barnes PJ
Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
[TBL] [Abstract][Full Text] [Related]
14. Emerging anti-inflammatory strategies for COPD.
Cazzola M; Page CP; Calzetta L; Matera MG
Eur Respir J; 2012 Sep; 40(3):724-41. PubMed ID: 22496331
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases.
Blease K; Raymon HK
Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment in asthma and COPD.
Hoshino T; Toda R; Aizawa H
Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
McNamara PS; Smyth RL
Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
[TBL] [Abstract][Full Text] [Related]
18. Immunology of asthma and chronic obstructive pulmonary disease.
Barnes PJ
Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
[TBL] [Abstract][Full Text] [Related]
19. [New pharmacological options in the therapy of COPD].
Watz H; Kanniess F; Magnussen H
Pneumologie; 2007 Jun; 61(6):365-73. PubMed ID: 17492578
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma.
Gorska K; Krenke R; Korczynski P; Kosciuch J; Domagala-Kulawik J; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():261-70. PubMed ID: 19218650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
